Brands
High Tide Acquires Premium Cannabis Brand Queen of Bud
LOS ANGELES- In a strategic move High Tide Inc. has officially completed its acquisition of the esteemed Queen of Bud brand, including its intellectual property, trademarks, and other valuable assets. This acquisition, announced on March 15, 2024, marks a significant expansion of High Tide's impressive portfolio of consumer-facing brands, such as NuLeaf Naturals, FAB CBD, ...
Optimi Health Corp. Expands Its Global Reach with MDMA Supply Agreement to Israeli Research Institute
LOS ANGELES – In a landmark move for psychedelic medicine, Optimi Health Corp., a preeminent manufacturer of psychedelics licensed by Health Canada, has announced a groundbreaking international supply agreement with The Institute for Psychedelic Research at Tel Aviv University (IPR-TLV). This partnership marks Optimi's inaugural foray into the Israeli market, establishing a significant milestone in ...
Numinus Wellness Secures $6 Million in Public Offering to Fuel Psychedelic-Assisted Therapy Initiatives
LOS ANGELES- Numinus Wellness, a Vancouver-based healthcare company specializing in the innovative field of psychedelic-assisted therapies, has announced the successful completion of a significant financial milestone. Through a "bought deal" public offering, the company has raised $6 million, a move that positions it strongly within the burgeoning sector of mental health care. Financial Details and ...
FSD Pharma Announces Market Offering Agreement to Fund Research and Development
NEW YORK- FSD Pharma a biopharmaceutical company focused on developing a diverse portfolio of innovative assets and biotechnological solutions, has unveiled a strategic market offering agreement with H.C. Wainwright & Co. LLC. This collaborative effort paves the way for FSD Pharma to potentially offer and sell up to $11,154,232 in Class B subordinate voting shares ...
Clearmind Medicine Inc. Advances Psychedelic Therapeutics with New Patent Applications
NEW YORK– Clearmind Medicine Inc. a biotech firm dedicated to the discovery and development of novel psychedelic-derived therapeutics, has taken significant steps to enhance its intellectual property (IP) portfolio through the submission of three patent applications under the international Patent Cooperation Treaty (PCT). This strategic move, in collaboration with SciSparc Ltd. (Nasdaq: SPRC), a clinical-stage ...
MindBio Therapeutics Announces Completion of Groundbreaking Phase 2a LSD Microdose Trial
LOS ANGELES- In a significant advancement for psychiatric medicine, MindBio Therapeutics Corp., a pioneering biopharmaceutical company, has announced the successful completion of its Phase 2a clinical trial, marking a pivotal moment in the development of treatments for Major Depressive Disorder (MDD). This trial is notably the world's first to receive regulatory approval for the take-home ...
Silo Pharma Advances in Ketamine-Based Treatment for Chronic Pain
LOS ANGELES— In a significant stride toward innovative treatment for chronic pain conditions, Silo Pharma, Inc. (Nasdaq: SILO), a biopharmaceutical company in its developmental stage, announced promising developments in its ketamine implant, SP-26. The company, known for its work on novel formulations and drug delivery systems for both traditional therapeutics and psychedelic treatments, is targeting ...
PharmaDrug Inc. Completes Private Placement to Bolster Corporate Initiatives
LOS ANGELES- a specialty pharmaceutical company, announce the successful completion of its previously disclosed non-brokered private placement, raising total gross proceeds of $326,000. In this offering, the company issued 6,520,000 units at a purchase price of $0.05 per unit, resulting in aggregate gross proceeds of up to $326,000. Each unit consists of one common share ...
Canopy Growth Reports Fiscal Q3 Earnings Amidst Strategic Shifts and Financial Hurdles
LOS ANGELES- Canopy Growth Corporation, reported a 7% decline in net revenue, amounting to $78.5 million for the fiscal third quarter ending December 31, 2023. The Smiths Falls, Ontario-based company revealed these figures in its latest earnings report, providing a mixed picture of its financial health and operational dynamics. All financial figures are reported in ...
Clearmind Medicine Secures Patent in China
LOS ANGELES- In a significant advancement for the field of psychedelic-derived therapeutics, Clearmind Medicine, a biotechnology firm with operations in Tel Aviv, Israel, and Vancouver, Canada, has been granted a patent in China for a novel treatment targeting binge behaviors. The treatment is based on a specific chemical compound known as a primary amine aminoindan, ...
Planet 13 Expands into Florida with Strategic Acquisition of VidaCann
LOS ANGELES- In a bold move aimed at broadening its footprint in the burgeoning U.S. cannabis market, Planet 13 has announced its acquisition of VidaCann, a significant player in the Florida cannabis sector. This all-stock transaction marks a pivotal moment for the Las Vegas-based company, allowing it to leverage VidaCann's established presence—including 26 retail locations ...
Psyence Biomedical Merges with Newcourt, Listing and Raising US$10 Million for Clinical Trials
LOS ANGELES- Psyence Biomedical Ltd. a subsidiary of Psyence Group Inc, has successfully completed a merger with Newcourt Acquisition Corp (“Newcourt”), a special purpose acquisition company. This business combination, which received approval from Newcourt’s stockholders on January 18, 2024, will introduce Psyence Biomed to the NASDAQ stock exchange under the new ticker symbols “PBM” for ...
PharmAla Launches “MDXXF” Ticker Amid MDMA Research
LOS ANGELES- PharmAla Biotech Holdings Inc., a biotechnology company specializing in the research, development, and manufacturing of novel MDMA derivatives (MDXX class molecules), has announced the introduction of its new OTC ticker symbol, "MDXXF." This change, effective from January 24th, signifies a strategic alignment with the company's core business focus. The announcement was made by ...
Incannex Healthcare Concludes Phase 2 Trial of Psilocybin Therapy for Anxiety Disorder, Awaiting FDA IND Application
LOS ANGELES- Incannex Healthcare Inc., a pharmaceutical company in the development of medicinal cannabinoid and psychedelic medicine therapies, has recently completed a significant milestone in its PsiGAD-1 clinical trial. This Phase 2 study, focused on evaluating the company’s proprietary psilocybin treatment for generalized anxiety disorder (GAD), successfully completed dosing and treatment protocols for all 72 ...
Irwin Naturals Inc. Reports Financial Performance in Q3 2023
LOS ANGELES- Irwin Naturals Inc, a key player in the cannabis and mental health sectors, recently disclosed its financial results for the third quarter of fiscal 2023, ending September 30, 2023. The report presents a complex picture of the company's financial health and strategic maneuvers in a rapidly evolving market. Financial Highlights for Q3 2023: Q3 ...
Ayr Wellness Dispensary in Las Vegas Joins Growing Trend of Cannabis Unionization
LAS VEGAS — Workers at a Las Vegas cannabis store, known as The Dispensary and operating under the Ayr Wellness brand, have elected to unionize with the United Food and Commercial Workers Union (UFCW) Local 711. This move represents a continuing trend of unionization within the cannabis sector across the nation. This specific Ayr Wellness ...
Building a Robust Brand: A Blueprint for Success in the Cannabis Industry
LOS ANGELES-- In a rapidly evolving market, cannabis companies are urged to adopt a nuanced approach to brand building, harmonizing seasoned cannabis expertise with established business principles to foster growth and sustainability. Steve Goldner, a leading branding expert in cannabis, writing here exclusively for Highly Capitalized, Goldner emphasizes the necessity of a well-rounded brand strategy ...
Cannabis Industry’s Branding Challenge: Beyond Packaging and Social Media
LOS ANGELES–Amid the flourishing cannabis industry, branding efforts often focus on packaging and social media, missing out on essential elements. Experts suggest that cannabis marketing needs to evolve beyond these basics to truly succeed. Cannabis companies must adopt Consumer Packaged Goods (CPG) methods like consumer insights to position and price their brands effectively. The transformative ...
Under Armour Signs $9 Million Deal with Hemp Black for Sustainable Yarn Supply
LOS ANGELES-- Hemp Black, a subsidiary of Australia-based Ecofibre, has entered into a significant supply agreement with global sports apparel brand Under Armour Inc. The deal, valued at $9 million annually, will involve Hemp Black providing specialty yarn made from its trademarked eco6 hemp biochar to Under Armour, as reported by Business News Australia. In ...
InMed Pharmaceuticals Evaluates Options for Promising INM-755 Compound After Successful Clinical Trial
LOS ANGELES-- Following the encouraging results of its Phase II clinical trial for INM-755, an anti-itch cannabinoid-based cream for skin disorders, InMed Pharmaceuticals (NASDAQ: INM) is now weighing its next steps to maximize value for shareholders. The trial showcased significant anti-itch activity, fueling the company's interest in exploring potential partnerships and developmental avenues for this ...
California’s Garden Society Announces Two-Fold Partnership with Kiva Confections and Kiva Sales and Service
LOS ANGELES-- California-based women-owned cannabis company, Garden Society, has recently announced a two-fold partnership with Kiva Confections and Kiva Sales and Service (KSS), a leader in the cannabis industry. In a bid to expand their market share, Garden Society will partner with KSS to sell and distribute their products to retailers state-wide, while Garden Society ...
High Tide and [Re] Waste Team Up to Celebrate Earth Day: A Revolutionary Initiative for Sustainable Cannabis Packaging
LOS ANGELES-- High Tide Inc. is making waves in the cannabis industry by leading the charge for environmentally responsible packaging solutions. In honor of Earth Day, the company is proudly partnering with [Re] Waste, an Alberta-based business that specializes in recycling hard-to-repurpose materials, to recycle single-use plastics from cannabis packaging. This unique partnership aims to ...
Curaleaf Granted Approval to Continue Selling Recreational Cannabis in New Jersey After Initial Denial
LOS ANGELES-- Curaleaf Holdings, a global provider of consumer cannabis products, has won a significant legal victory in New Jersey. The New Jersey Cannabis Regulatory Board reversed its earlier decision to deny the company's adult-use cannabis licenses. The board met on Monday, April 17th, to reconsider the renewal of Curaleaf's cultivation and sales licenses. The ...
Pervasip Corp Acquires Slurped & Starts Nano Emulsified Products’ Division
LOS ANGELES-- Pervasip Corp, a developer of companies and technologies in high value emerging markets, has announced the acquisition of Slurped, a nano tincture brand, and the establishment of Artizen Nano, a division focused on the development of nano emulsified products. The acquisition of United Consulting Services (UCS) has enabled Pervasip to implement the Artizen ...
Cornbread Hemp Closes Successful Seed Round
LOS ANGELES-- Cornbread Hemp, a top-selling CBD brand in the US, announced the successful closing of their seed round of fundraising and the acquisition of their processing and manufacturing partner. This move marks a significant milestone for the Kentucky-based company, which has been experiencing exponential growth since its founding in 2019. Cornbread Hemp has projected ...
